Novo Nordisk, A/S is a global pharmaceutical company headquartered in Denmark. With a focus on diabetes care, Novo Nordisk develops and manufactures a wide range of innovative products and treatments for people living with diabetes. Their portfolio includes insulin, GLP-1 analogs, and other medications that help manage blood sugar levels and improve overall health. Committed to research and development, Novo Nordisk strives to improve the lives of individuals with diabetes through their cutting-edge therapies and ongoing efforts to find new solutions for this chronic condition.
Generated from the website